Your email has been successfully added to our mailing list.

×
0 0 0 0 0.00346020761245667 0 0.0242214532871972 0.013840830449827
Stock impact report

Orchard Therapeutics Outlines Differentiated Profile of Its HSC Gene Therapy Approach and Discusses Potential Future Applications at Virtual R&D Investor Event

Orchard Therapeutics plc - American Depositary Shares (ORTX)  More Company Research Source: GlobeNewswire
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report
PDF Novel Discovery Research in HSC-generated Antigen-specific Regulatory T Cells Disclosed HSC Gene Therapy Also Provides Advantages for Delivery of Monoclonal Antibodies New Applications Present Opportunities for Future Partnerships BOSTON and LONDON, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today will present on the company’s discovery and research efforts in hematopoietic stem cell (HSC) gene therapy, including an update on the OTL-104 program in development for NOD2 Crohn’s disease (NOD2-CD), together with overviews of potential new applications in the areas of HSC-generated antigen-specific regulatory T cells (Tregs) and HSC-vectorization of monoclonal antibodies (mAbs). A live webcast of the presentation will be available in the Investors & Media section of the company’s website at www.orchard-tx.com today at 7:00 a.m. ET. “Today, we present the next chapter in Orchard’s journey as a leader in HSC gene therapy, incl [Read more]
Impact snapshot Event time: ORTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ORTX alerts
from News Quantified
Opt-in for
ORTX alerts

from News Quantified
Opt-in for
ORTX alerts

from News Quantified